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favourable scientific development contributing valuable research
in various fields of the life sciences. In this stimulating context,
South American based scientists have substantially increased their
rate of publication in the recent years. The present South America
Special Issue aims at bringing together for the first time into a sin-
gle volume a sample of current research in life sciences carried out
in the region. We have assembled what we believe is a reputable
group of innovative and interdisciplinary researchers, who con-
tributed reviews in a broad range of disciplines in the life sciences,
particularly Neuroscience, Molecular, Structural and Stem Cell
Biology, Immunology and Cancer.
The topics were selected based on the current focus and pro-
duction in these fields, and also on the historical development in
the region. Despite serious economic and political challenges, a tra-
dition of basic research developed in Argentina. Scientific excel-
lence was reached in 1947 when Bernardo Houssay became
Argentina’s first scientific Nobel Laureate by winning the prize
for Physiology and Medicine. This School in biomedicine and bio-
chemistry lead to the subsequent Nobel Laureates, Federico Leloir
in Chemistry in 1970 and Cesar Milstein in Physiology and Medi-
cine in 1984. Such tradition is still influencing current research
and has reached an internationally recognized level, fostered in
the last 12 years by a public policy promoting research and
technology.
The development of neuroscience in South America started at
the end of the nineteenth century, with dozens of scientists and
neurologists trained in Europe and spreading in Argentina, Brazil,
Chile, Uruguay and Peru. This early generation of neuroscientists
described some relevant regional diseases such a Cysticercosis,
viral encephalitis, Huntington and Chagas disease, among others.
More recent generations made valuable contributions in electro-
physiology, histology, cell biology and behavioural neuroscience.
A program dedicated to neuroscience is being launched in the lar-
gest biomedical research institution in South America, The
Oswaldo Cruz Foundation in Rio de Janeiro, Brazil. Immunology
and Cell Biology are also very strong fields of research in South
America. In the last few years, the city of Rio de Janeiro held the
International Congress of Immunology (2007) and the World Con-
gress on Cell Biology (2012). Following the pioneering work of
Oswaldo Cruz, Salvador Mazza and Carlos Chagas, the South Amer-
ican scientific community largely contributes to the knowledge in
infectious diseases, particularly those considered as neglected dis-
eases, such as Chagas disease, Leishmaniasis, Schistosomiasis, and
Leprosy among others.
During the last two decades there was a significant increase in
the scientific production in South America, based mainly on theincrease in the public investment and the strong commitment of
the regional governments with Science and Technology. In regard
to the number of researchers, Brazil has a staff of over 100,000,
almost two-thirds of South America’s scientists, and Argentina
has the highest proportion of researchers with nearly 3 per 1000
workers. Brazil and Argentina lead the bi-national collaborative
research with over 3000 projects between the two countries. South
America, however, still has a relatively low number of registered
patents. In the last years major efforts have been made to bring sci-
entists back to their home countries, particularly in Chile, Uruguay,
Argentina and Brazil. Notably, the Argentinian RAICES Program and
the Brazilian Science without Borders program have made signifi-
cant contributions.
In this context, the first South-American network for research in
Biomedicine has been created and receives funding from the MER-
COSUR (the CommonMarket of the South) through the FOCEM (the
Budget for Structural Convergence of MERCOSUR). This network in
biomedicine was formed by research institutions from Argentina,
Brazil, Paraguay and Uruguay. This is the first time that MERCOSUR
financially supports a multi-national project for scientific research
and education, suggesting that nowadays investment in science,
education and technology is considered a landmark of structural
stability for national governments. Among its objectives the bio-
medicine network aims at studying the biological and epidemio-
logical aspects of diseases, as well as developing excellence in
the training of human resources, promoting the acquisition of state
of the art technology and the interaction between investigators in
the region. This innovative approach of working together with
integrated efforts in biomedicine will sow the seeds for other sci-
entific endeavours in South America. The guest Editors of this issue
of FEBS Letters are directors of three Institutes participating in the
network and celebrate this Special Issue as an interesting and cre-
ative initiative to bring together scientists in the region.
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